Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Seth Furgeson to Humans

This is a "connection" page, showing publications Seth Furgeson has written about Humans.

 
Connection Strength
 
 
 
0.114
 
  1. Furgeson SB, Linas S. Chlorthalidone and Advanced Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 07; 17(7):1076-1078.
    View in: PubMed
    Score: 0.020
  2. Montford JR, Furgeson SB. A new CTGF target in renal?fibrosis. Kidney Int. 2017 10; 92(4):784-786.
    View in: PubMed
    Score: 0.015
  3. Montford JR, Lehman AM, Scobey MS, Weiser-Evans MC, Nemenoff RA, Furgeson SB. Cytosolic phospholipase A2a increases proliferation and de-differentiation of human renal tubular epithelial cells. Prostaglandins Other Lipid Mediat. 2016 11; 126:1-8.
    View in: PubMed
    Score: 0.014
  4. Furgeson SB, Teitelbaum I. Basically, dialysis is not good enough. Clin J Am Soc Nephrol. 2013 Feb; 8(2):177-8.
    View in: PubMed
    Score: 0.011
  5. Furgeson SB, Linas S. Mechanisms of type I and type II pseudohypoaldosteronism. J Am Soc Nephrol. 2010 Nov; 21(11):1842-5.
    View in: PubMed
    Score: 0.009
  6. Furgeson SB, Teitelbaum I. New treatment options and protocols for peritoneal dialysis-related peritonitis. Contrib Nephrol. 2009; 163:169-176.
    View in: PubMed
    Score: 0.008
  7. Furgeson SB, Chonchol M. Beta-blockade in chronic dialysis patients. Semin Dial. 2008 Jan-Feb; 21(1):43-8.
    View in: PubMed
    Score: 0.007
  8. Zhang A, Furgeson S, Shapiro A, Bjornstad P, You Z, Tommerdahl KL, Dixon A, Stenson E, Oh E, Kendrick J. Assessing Cognition in CKD Using the National Institutes of Health Toolbox. Kidney360. 2024 Jun 01; 5(6):834-840.
    View in: PubMed
    Score: 0.006
  9. Floyd D, Colbert JF, Feng F, Furgeson SB, Montford JR. Acute and Chronic Kidney Disease Worsen Outcomes in Experimental Sepsis. Kidney360. 2024 May 01; 5(5):654-670.
    View in: PubMed
    Score: 0.006
  10. Kleczko EK, Nguyen DT, Marsh KH, Bauer CD, Li AS, Monaghan MT, Berger MD, Furgeson SB, Gitomer BY, Chonchol MB, Clambey ET, Zimmerman KA, Nemenoff RA, Hopp K. Immune checkpoint activity regulates polycystic kidney disease progression. JCI Insight. 2023 06 22; 8(12).
    View in: PubMed
    Score: 0.005
  11. Beck N, Furgeson S, Chonchol M, Kendrick J. Internal Medicine Residents' Perceptions of Nephrology as a Career: A Focus Group Study. Kidney360. 2020 10 29; 1(10):1052-1059.
    View in: PubMed
    Score: 0.004
  12. Kleczko EK, Marsh KH, Tyler LC, Furgeson SB, Bullock BL, Altmann CJ, Miyazaki M, Gitomer BY, Harris PC, Weiser-Evans MCM, Chonchol MB, Clambey ET, Nemenoff RA, Hopp K. CD8+ T cells modulate autosomal dominant polycystic kidney disease progression. Kidney Int. 2018 12; 94(6):1127-1140.
    View in: PubMed
    Score: 0.004
  13. Moulton KS, Li M, Strand K, Burgett S, McClatchey P, Tucker R, Furgeson SB, Lu S, Kirkpatrick B, Cleveland JC, Nemenoff RA, Ambardekar AV, Weiser-Evans MC. PTEN deficiency promotes pathological vascular remodeling of human coronary arteries. JCI Insight. 2018 02 22; 3(4).
    View in: PubMed
    Score: 0.004
  14. Gonzalez OY, Musher DM, Brar I, Furgeson S, Boktour MR, Septimus EJ, Hamill RJ, Graviss EA. Spectrum of bacille Calmette-Gu?rin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis. 2003 Jan 15; 36(2):140-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)